M. Obeid

Immune checkpoint inhibitor-related myositis and myocarditis: diagnostic pitfalls and imaging contribution in a real-world, institutional case series

F. Becce, A. Hottinger, S. Latifyan, 2023, Journal of neurology.

Management of toxicities from immunotherapy: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up.

S. Peters, J. Haanen, C. Robert, 2022, Annals of oncology : official journal of the European Society for Medical Oncology.

Primary prophylaxis with mTOR inhibitor enhances T cell effector function and prevents heart transplant rejection during talimogene laherparepvec therapy of squamous cell carcinoma

M. Pruijm, D. Daoudlarian, Victor S. Joo, 2024, Nature communications.

Predictors and Risk Score for Immune Checkpoint-Inhibitor-Associated Myocarditis Severity

J. Cautela, S. Sandhu, Alan H. Baik, 2024, medRxiv.